首页> 外文OA文献 >Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin

【2h】

Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin

机译：通过抗CD20嵌合抗原受体（CAR）修饰的扩大的自然杀手（NK）细胞结合组蛋白去乙酰化酶抑制剂Romidepsin增强靶向B细胞淋巴瘤/白血病（B-L / L）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chu Yay; Yahr Ashlin; Lo Lowrence; Ayello Janet; Katz Jared; Cairo Mitchell S.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effectively Targeting Burkitt Lymphoma By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and In Humanized NSG Mice [J] . Chu Yaya, Yahr Ashlin, Ayello Janet, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：有效地靶向Burkitt淋巴瘤的抗CD20嵌合抗原受体（CAR）修饰的扩大的自然杀伤细胞结合组蛋白去乙酰化酶抑制剂，Romidepsin的体外和人源化NSG小鼠。
2. Enhanced in-Vitro and in-Vivo Targeting of Rituximab Sensitive and Resistant Burkitt Lymphoma (BL) By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells in Combination with a Histone Deacetylase Inhibitor, Romidepsin [J] . Chu Yaya, Yahr Ashlin, Cheng Bokun, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第3Suppla1期

机译：通过抗CD20嵌合抗原受体（CAR）修饰的扩大的天然杀伤细胞与组蛋白脱乙酰基酶抑制剂Romidepsin的结合，增强了利妥昔单抗敏感和耐药Burkitt淋巴瘤（BL）的体外和体内靶向
3. ENHANCED IN-VITRO AND IN-VIVO TARGETING OF RITUXIMAB SENSITIVE AND RESISTANT BURKITT LYMPHOMA (BL) BY ANTI-CD20 CHIMERIC ANTIGEN RECEPTOR (CAR) MODIFIED EXPANDED NATURAL KILLER CELLS IN COMBINATION WITH A HISTONE DEACETYLASE INHIBITOR, ROMIDEPSIN [J] . Chu Yaya, Yahr Ashlin, Cheng Bokun, Pediatric blood & cancer . 2016,第Suppla1期

机译：抗CD20嵌合抗原受体（CAR）修饰的扩增天然杀伤细胞与组蛋白去乙酰化酶抑制剂联用可增强利妥昔单抗敏感性和耐药性伯克氏淋巴瘤（BL）的体外和体内靶向
4. REMOVAL OF MYELOID CELLS FROM AUTOLOGOUS LEUKOCYTES USED FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL MANUFACTURING IMPROVES FINAL PRODUCT CONSISTENCY AND YIELDS [C] . David Stroncek, Daniel W. Lee, Marianna Sabatino, Scale-up and manufacturing of cell-based therapies V . 2017

机译：从用于嵌合抗原受体（CAR）T细胞制造的自体白细胞去除髓样细胞可改善最终产品的一致性和产量
5. LAMININ: A POSSIBLE ROLE AS A MEDIATOR OF NATURAL CELL-MEDIATED FUNCTIONS (NATURAL KILLER CELLS, NATURAL CYTOTOXIC CELLS, RECEPTORS, SURFACE ANTIGEN). [D] . LAYBOURN, KATHERINE ANN. 1986

机译：层粘连蛋白：作为天然细胞介导的功能（天然杀伤细胞，天然细胞毒性细胞，受体，表面抗原）的介体的可能作用。
6. Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice [O] . Yaya Chu, Ashlin Yahr, Brian Huang, 2017

机译：单独或与抗CD20嵌合抗原受体联合使用罗米地辛在体外和免疫缺陷小鼠中靶向Burkitt淋巴瘤的天然杀伤细胞扩增
7. Effectively Targeting Burkitt Lymphoma By Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin in Vitro and In Humanized NSG Mice [O] . Chu Yaya, Yahr Ashlin, Ayello Janet, 2015

机译：通过抗CD20嵌合抗原受体（CAR）修饰的天然杀伤细胞与组蛋白脱乙酰基酶抑制剂罗米地辛的体外和人源化NSG小鼠有效靶向Burkitt淋巴瘤

Enhanced Targeting B Cell Lymphoma/Leukemia (B-L/L) by Anti-CD20 Chimeric Antigen Receptor (CAR) Modified Expanded Natural Killer (NK) Cells Combined with a Histone Deacetylase Inhibitor, Romidepsin

著录项

引文网络

相似文献

相关主题

期刊订阅